Back to
JPMORGAN CHASE & CO
ALNY8 quarters
Position history for
JPMORGAN CHASE & CO's holdings in ALNYLAM PHARMACEUTICALS INC
Yes. JPMorgan Chase holds 2,675,517 shares of ALNY (Alnylam Pharmaceuticals), worth $785.3M, as of its Q2 2026 13F filing. It reduced the position by 3,648,235 shares (-57.7%) from Q1 2026. JPMorgan Chase has held ALNY in every 13F on record since Q3 2024, 8 quarterly filings.
Current Value
$785.3M
Current Shares
2.7M
Total Value Change
+$190.4M
Total Shares Change
+512,573
Quarter-by-Quarter History
Other major holders of ALNY: FMR LLC, Capital World Investors, VANGUARD GROUP INC